Pregnancy Outcomes After Chemotherapy For Gestational Trophoblast Neoplasia
DOI:
https://doi.org/10.52764/jms.22.30.2.3Keywords:
Gestational Trophoblast Neoplasia(GTN), FIGO Prognostic score (International federation of Gynaecologist& Obstetrician) ,Mortality, ChemotherapyAbstract
Objective: To find the outcomes of pregnancy in women who conceived after chemotherapy & to establish the safety of chemotherapeutic regimen used for the treatment of GTN in women of reproductive age.
Materials & Methods: Prospective cohort Follow up study done at Department of obstetrics & gynaecology, Hayatabad Medical Complex, Peshawar, Pakistan. 90 women with the diagnosis of GTN were hospitalized & treated according to standard chemotherapeutic regimens between june 2005-2014, they were followed up for a period of five years. Patients demographic profile, FIGO score, type of chemotherapy, treatment & pregnancy outcomes were recorded on predesigned performa and computerized record was kept. Data analysis done through SPSS 16.
Results: In 90 patients diagnosed with GTN, 59(65.6%) patients were low risk and 31(34.4 %) were in high risk category . Overall survival was 100% in low risk category and 70.58% in high risk category.
9 women conceived during first year of follow up while 35 conceived afterwards.
44 patients conceived with 38(86.3%) having live term births without congenital abnormalities.
5 women had miscarriage,1 had repeat molar pregnancy, while 4 women experienced live twin birth after chemotherapy for GTN.
Conclusions: Current chemotherapeutic regimens used in treatment of gestational trophoblast neoplasia are highly effective, safe & preserves fertility. Women should expect normal reproductive outcomes similar to general population after treatment of gestational trophoblast neoplasia.
Key words: Gestational Trophoblast Neoplasia(GTN), FIGO Prognostic score (International federation of Gynaecologist& Obstetrician) ,Mortality, Chemotherapy
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
